TYRA offering history
Every offering-related filing in Tyra Biosciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 410 filings back to May 28, 2021.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 4, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 16, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 8, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 18, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 22, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 19, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 5, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 13, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 3, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 15, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 14, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 14, 2021 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Sep 14, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 9, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Aug 20, 2021 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
TYRA offering FAQ
When did TYRA last execute an offering?
Per SEC filings, Tyra Biosciences, Inc.'s most recent priced offering document is a 424B5 filed 2026-08-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did TYRA last announce or register an offering?
The most recent registration is a S-3 filed 2025-05-08. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.